The case, involving a supplement intended to reduce cholesterol, has put attention on how companies are allowed to self-report claims about their products.
https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png00https://siii-clinical.com/wp-content/uploads/2021/09/Untitled-1.png2024-06-28 13:03:432024-06-28 13:03:43Deaths Linked to Japanese Supplement Suddenly Rise to 80
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.